US stocks gained steam on Thursday afternoon as investors digested megacap tech earnings and waited for Apple (AAPL) results ...
"During the past 24 months or so, Apple has been the stock everyone has loved to hate, and that trend has continued into 2025," Rubin told clients in a new note. "Apple has been left behind in this ...
Earnings and guidance still matter most when it comes down to real decisions about buying, holding and selling stocks. An old-school big tech stock was among the day's biggest upside movers, while a ...
Jeffrey Eisele, the Chief Development Officer at Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.8 billion market cap biopharmaceutical company, recently sold a portion of his holdings in the ...